EORTC Radiation Oncology Group

 
brain breast head & neck prostate lung rectum sarcoma non-EORTC trials On-going trials continued
Home about us Achievements Group officers Group structure Working parties Group meetings Quality assurance On-going trials EORTC-ROG Guidelines RT Technologists ROG-HQ Team For members only
 

head & neck

 

 

22071-24071

Randomized phase III trial on postoperative chemoradiation in combination with an EGFR-antibody versus postoperative chemoradiation in head and neck squamous cell carcinoma (HNSCC) with high risk of locoregional recurrence (W. Budach, H.Langendijk)

design
         
         
​ ​ ​ ​